This issue of Cardiac Electrophysiology Clinics, Guest Edited by Drs. Mohammad Shenasa, Prashanthan Sanders, and Stanley Nattel, is dedicated to Risk Factors in Atrial Fibrillation: Appraisal of AF Risk Stratification. This is one of four issues selected each year by the series Consulting Editors, Ranjan K. Thakur and Andrea Natale. Topics include, but are not limited to, Epidemiology of Atrial Fibrillation; Hypertension, Prehypertension, Hypertensive Heart Disease and Atrial Fibrillation; Pulmonary Disease, Pulmonary Hypertension and Atrial Fibrillation; Heart Failure with Preserved (HFpEF) and Reduced (HFrEF) LV Systolic Function, Diastolic Dysfunction; Coronary Artery Disease; ECG and Echo Abnormalities in Patients with Atrial Fibrillation Risk Factors; Diabetes and Endocrine Disorders; Obesity and Metabolic Syndrome in Atrial Fibrillation; Renal Disease; Sleep Apnea and Atrial Fibrillation; Channelopathies in Atrial Fibrillation; Implications of Inflammation and Myocardial Fibrosis in Atrial Fibrillation; Role of Biomarkers in Atrial Fibrillation; Left Ventricular Hypertrophy and Other Cardiomyopathies in Atrial Fibrillation; Atrial Fibrillation in Valvular Heart Disease; Atrial Fibrillation in Adult Congenital Heart Disease; Exercise and Athletic Activity in Atrial Fibrillation; Post-op Atrial Fibrillation; Autonomic Dysfunction and Neurohormonal Disorders in Atrial Fibrillation; Social Risk Factors; Atrial Fibrillation and Stroke; Screening for Atrial Fibrillation Risk Factors; Primary Care and Internists Perspective on Atrial Fibrillation Risk Factors; and Lifestyle as a Risk Factor for Atrial Fibrillation.

This issue of Cardiac Electrophysiology Clinics, Guest Edited by Drs. Mohammad Shenasa, Prashanthan Sanders, and Stanley Nattel, is dedicated to Risk Factors in Atrial Fibrillation: Appraisal of AF Risk Stratification. This is one of four issues selected each year by the series Consulting Editors, Ranjan K. Thakur and Andrea Natale. Topics include, but are not limited to, Epidemiology of Atrial Fibrillation; Hypertension, Prehypertension, Hypertensive Heart Disease and Atrial Fibrillation; Pulmonary Disease, Pulmonary Hypertension and Atrial Fibrillation; Heart Failure with Preserved (HFpEF) and Reduced (HFrEF) LV Systolic Function, Diastolic Dysfunction; Coronary Artery Disease; ECG and Echo Abnormalities in Patients with Atrial Fibrillation Risk Factors; Diabetes and Endocrine Disorders; Obesity and Metabolic Syndrome in Atrial Fibrillation; Renal Disease; Sleep Apnea and Atrial Fibrillation; Channelopathies in Atrial Fibrillation; Implications of Inflammation and Myocardial Fibrosis in Atrial Fibrillation; Role of Biomarkers in Atrial Fibrillation; Left Ventricular Hypertrophy and Other Cardiomyopathies in Atrial Fibrillation; Atrial Fibrillation in Valvular Heart Disease; Atrial Fibrillation in Adult Congenital Heart Disease; Exercise and Athletic Activity in Atrial Fibrillation; Post-op Atrial Fibrillation; Autonomic Dysfunction and Neurohormonal Disorders in Atrial Fibrillation; Social Risk Factors; Atrial Fibrillation and Stroke; Screening for Atrial Fibrillation Risk Factors; Primary Care and Internists Perspective on Atrial Fibrillation Risk Factors; and Lifestyle as a Risk Factor for Atrial Fibrillation.

In collaboration with the Consulting Editors, Ranjan K. Thakur and Andrea Natale, Drs. Luigi Di Biase, Frank Marchlinski, and Andrea Natale have assembled an issue of Cardiac Electrophysiology Clinics on Advances in Atrial Fibrillation Ablation. Topics include, but are not limited to, Recurrent atrial fibrillation with isolated PVs, Beyond PVI in non paroxysmal atrial fibrillation, Recurrent atrial fibrillation after cryo, Recurrent atrial fibrillation after RF, high-density mapping, Expectation and Results of surrogate target beyond PVI, Lessons from epicardial mapping and ablation in refractory atrial fibrillation, Evolution of radiofrequency ablation parameters, Balloon based technologies, Energy sources, Current status of esophageal protection, Fluoroless atrial fibrillation ablation, Role of MRI imaging before and after ablation, When to stop OAC after atrial fibrillation ablation, Atrial fibrillation ablation trials, Risk Factor modification before and after atrial fibrillation ablation.

Get a quick, expert overview of stroke risks among patients with treated and untreated atrial fibrillation, in addition to best practices for management and treatment of patients with atrial fibrillation to minimize stroke risks. This concise, clinically-focused resource by Dr. Greg Flaker consolidates today's available information on this timely topic into one convenient resource, making it an ideal, easy-to-digest reference for practicing and trainee cardiologists as well as general practitioners treating and monitoring these patients. - Covers a broad spectrum of management and treatment options for atrial fibrillation including anticoagulants, surgical and implanted devices. - Presents information on recent drug trials to keep you up to date with the latest developments. - Includes guidance on anticoagulation in special situations, such as cardioversion and ablation, in addition to atrial fibrillation treatment in patients with other medical conditions including cancer, major bleeding disorders, and renal or liver disease. - Chapter on Risk Stratification assists in identifying patients with a high risk of stroke and predicting treatment outcomes. - Chapter on The New Anticoagulation Clinic overviews best practices for patient education, compliance, follow-up monitoring, and quality assurance to aid in better patient outcomes.

With over 6 million patients affected only in the United States, atrial fibrillation (AF) is a major health problem with profound effects on both the individual patient and society at large. In this issue of Heart Failure Clinics, we have focused on AF and tried to cover the most important and relevant aspects in a comprehensive and contemporary review. A distinguished group of experts and leaders in basic and experimental electrophysiology, epidemiology, clinical pharmacology, interventional clinical electrophysiology, and cardiac surgery contributed state-of-the-art reviews and also shared their insight to the future of AF. Topics include but are not limited to: Risk Factors and Genetics of Atrial Fibrillation; Mechanisms of Atrial Fibrillation: Rotors, Ionic Determinants, and Excitation Frequency; Diagnostic Evaluation and Follow-Up of Patients with Atrial Fibrillation; Catheter Ablation of Atrial Fibrillation; Antithrombotic and Anticoagulant Therapy for Atrial Fibrillation; Postoperative Atrial Fibrillation: Incidence, Mechanisms, and Clinical Correlates; and Novel Upstream Approaches to Prevent Atrial Fibrillation Perpetuation.

Because atrial fibrillation promotes the formation of blood clots that can travel to the brain and block an artery, atrial fibrillation independently increases the risk of ischemic stroke four-to-five-fold. In this issue expert authors review drug therapies for stroke prevention, use of the new anticoagulants, ablation strategies for stroke prevention, LAA closure for stroke prevention, stroke in heart rhythm device patients, transesophageal echo in atrial fibrillation, and other topics important to the management of this serious complication.

Atrial Fibrillation-Basic Research and Clinical Applications is designed to provide a comprehensive review and to introduce outstanding and novel researches. This book contains 22 polished chapters and consists of five sections: 1. Basic mechanisms of initiation and maintenance of atrial fibrillation and its pathophysiology, 2. Mapping of atrial fibrillation and novel methods of signal detection. 3. Clinical prognostic predictors of atrial fibrillation and remodeling, 4. Systemic reviews of catheter-based/surgical treatment and novel targets for treatment of atrial fibrillation and 5. Atrial fibrillation in specific conditions and its complications. Each chapter updates the knowledge of atrial fibrillation, providing state-of-the art for not only scientists and clinicians who are interested in electrophysiology, but also general cardiologists.

Atrial Fibrillation: A Multidisciplinary Approach to Improving Patient Outcomes, provides a current and comprehensive update on path physiology, epidemiology, management strategies of rate control, pharmacologic and nonpharmacologic approaches to rhythm control, risk stratification for stroke and bleeding, anticoagulant therapy, and left atrial occlusion devices. The contributions by experienced internists, cardiologists, electrophysiologists, surgeons, anesthesiologists, pharmacists, internists, nurse practitioners, and nurse educators provide a unique perspective. Case studies of paroxysmal, persistent, and permanent atrial provide clinical context incorporating recent evidence and best practices for the multidisciplinary approach to improving patient outcomes. “The physician is inundated with information, and needs all of this to be reduced and summarized in a readable form. This cannot be done simply by technical editing because it involves real expertise to pick the “jewels for the crown.” This has been accomplished so well by the authors who have contributed to this book. The result is a gem — a source of enlightenment for all the many clinicians who care for patients suffering from this ubiquitous arrhythmia. I read it from cover to cover in about three hours, and learned much which is new and useful to my practice. It is the best small book that I know dealing with this big subject.” -From the foreword by A. John Camm, MD

This book addresses the problem of atrial fibrillation in terms of epidemiology, risk factors, as well as treatment, including medical treatment using drugs, catheter ablation, and cardiac surgery. Most of the authors of the book are arrhythmologists, and chapters on atrial fibrillation are based on their experience in the cardiology clinic or the operating room.

In collaboration with the Consulting Editors, Ranjan K. Thakur and Andrea Natale, Drs. Luigi Di Biase, Frank Marchlinski, and Andrea Natale have assembled an issue of Cardiac Electrophysiology Clinics on Advances in Atrial Fibrillation Ablation. Topics include, but are not limited to, Recurrent atrial fibrillation with isolated PVs, Beyond PVI in non paroxysmal atrial fibrillation, Recurrent atrial fibrillation after cryo, Recurrent atrial fibrillation after RF, high-density mapping, Expectation and Results of surrogate target beyond PVI, Lessons from epicardial mapping and ablation in refractory atrial fibrillation, Evolution of radiofrequency ablation parameters, Balloon based technologies, Energy sources, Current status of esophageal protection, Fluoroless atrial fibrillation ablation, Role of MRI imaging before and after ablation, When to stop OAC after atrial fibrillation ablation, Atrial fibrillation ablation trials, Risk Factor modification before and after atrial fibrillation ablation.